Oscar Health (NYSE:OSCR) Sees Large Volume Increase – What’s Next?

Shares of Oscar Health, Inc. (NYSE:OSCR) saw an uptick in trading volume on Wednesday . 4,541,314 shares changed hands during mid-day trading, an increase of 36% from the previous session’s volume of 3,346,029 shares.The stock last traded at $15.44 and had previously closed at $15.28.

Analyst Upgrades and Downgrades

OSCR has been the subject of several research analyst reports. Jefferies Financial Group began coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Oscar Health has a consensus rating of “Hold” and a consensus target price of $21.56.

Oscar Health Trading Up 4.6 %

The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm’s 50 day moving average price is $15.20 and its 200 day moving average price is $16.85. The stock has a market capitalization of $3.95 billion, a P/E ratio of -265.17, a P/E/G ratio of 0.67 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. As a group, equities research analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Oscar Health news, CFO Richard Scott Blackley sold 25,279 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $457,044.32. Following the completion of the transaction, the chief financial officer now owns 881,841 shares in the company, valued at $15,943,685.28. This trade represents a 2.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at $2,640,330.88. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders acquired 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently bought and sold shares of OSCR. KBC Group NV increased its position in Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after acquiring an additional 1,328 shares during the last quarter. Optimum Investment Advisors bought a new position in Oscar Health during the 3rd quarter valued at about $142,000. ORG Wealth Partners LLC purchased a new stake in Oscar Health in the 4th quarter worth about $100,000. Aigen Investment Management LP bought a new stake in Oscar Health in the third quarter worth about $205,000. Finally, Alberta Investment Management Corp purchased a new position in shares of Oscar Health during the fourth quarter valued at approximately $138,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.